Direct Healthcare Professional Communications (DHPC) - Valproate (Depakine®, Depakine Chrono®, Valproate Chrono Sanofi®, Valproate Chrono Desitin®, Orfiril® long, Orfiril®, Valproate Sandoz®, Convulex®)
17. August 2023 – New information on the potential risk for neurodevelopmental disorders in children of fathers treated with valproate compared to children of fathers treated with lamotrigine or levetiracetam.
For more information, see here.